Meditera Tibbi Malzeme Sanayi ve Ticaret AS Working Capital to Net Assets Ratio
Meditera Tibbi Malzeme Sanayi ve Ticaret AS working capital to net assets ratio. Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) has a Working Capital to Net Assets ratio of 43.2% as of March 2026. Working capital of TL1.37 Billion (current assets of TL1.90 Billion minus current liabilities of TL530.71 Million) is measured against net assets of TL3.17 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible equity quality of Meditera Tibbi Malzeme Sanayi ve Ticaret to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Meditera Tibbi Malzeme Sanayi ve Ticaret AS (2018–2025)
Working capital to net assets ratio of Meditera Tibbi Malzeme Sanayi ve Ticaret AS from 2018 to 2025. This chart shows how Meditera Tibbi Malzeme Sanayi ve Ticaret AS's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2018 to 2025. As of March 2026, the ratio stands at 43.2%, reflecting working capital of TL1.37 Billion against net assets of TL3.17 Billion TRY. See Meditera Tibbi Malzeme Sanayi ve Ticaret (MEDTR) defensive interval to measure how many days the company can operate on defensive assets alone.
Meditera Tibbi Malzeme Sanayi ve Ticaret AS Working Capital to Net Assets Ratio by Year (2018–2025)
Meditera Tibbi Malzeme Sanayi ve Ticaret AS working capital to net assets ratio by year from 2018 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Meditera Tibbi Malzeme Sanayi ve Ticaret AS from 2018 to 2025, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see MEDTR total assets.
| Year | WC/NA Ratio | Working Capital (TRY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 43.7% | TL1.28 Billion | TL2.93 Billion | TL1.82 Billion | TL541.53 Million | ▼ -5.3 pp |
| 2024 | 48.9% | TL1.43 Billion | TL2.93 Billion | TL2.03 Billion | TL601.28 Million | ▼ -4.8 pp |
| 2023 | 53.8% | TL1.15 Billion | TL2.14 Billion | TL1.56 Billion | TL411.08 Million | ▼ -11.1 pp |
| 2022 | 64.8% | TL575.21 Million | TL887.08 Million | TL720.12 Million | TL144.92 Million | ▼ -21.4 pp |
| 2021 | 86.3% | TL491.30 Million | TL569.37 Million | TL618.34 Million | TL127.04 Million | ▲ +15.6 pp |
| 2020 | 70.7% | TL153.51 Million | TL217.15 Million | TL241.13 Million | TL87.62 Million | ▼ -2.8 pp |
| 2019 | 73.5% | TL92.97 Million | TL126.49 Million | TL166.01 Million | TL73.03 Million | ▼ -12.2 pp |
| 2018 | 85.7% | TL92.63 Million | TL108.11 Million | TL153.28 Million | TL60.65 Million | — |